Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice

被引:22
作者
Alper, Kenneth [1 ,2 ]
Cange, Janelle [3 ]
Sah, Ria [4 ]
Schreiber-Gregory, Deanna [5 ]
Sershen, Henry [1 ,6 ]
Vinod, K. Yaragudri [4 ,7 ,8 ]
机构
[1] NYU Grossman Sch Med, Dept Psychiat, New York, NY 10016 USA
[2] NYU Grossman Sch Med, Dept Neurol, New York, NY 10016 USA
[3] Nathan S Kline Inst Psychiat Res, Div Lab Anim Resources, Orangeburg, NY USA
[4] Nathan S Kline Inst Psychiat Res, Dept Analyt Psychopharmacol, Orangeburg, NY 10962 USA
[5] Juxdapoze Stat Consulting, Rockville, MD USA
[6] Nathan S Kline Inst Psychiat Res, Dept Neurochem, Orangeburg, NY USA
[7] Emot Brain Inst, Orangeburg, NY 10962 USA
[8] NYU Grossman Sch Med, Dept Child & Adolescent Psychiat, New York, NY 10016 USA
关键词
alcohol; hallucinogen; lysergic acid diethylamide; psilocybin; psychedelic; mouse; serotonin receptor 5-HT2A agonist; substance-related and addictive disorders; ETHANOL DRINKING; RECEPTOR; 5-HT2A; PREFERENCE; REDUCTION; BEHAVIOR; LSD;
D O I
10.3389/fphar.2022.1074633
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The classical psychedelic psilocybin is of interest as a treatment for alcohol use disorder (AUD). This study investigated the effects of psilocybin on voluntary ethanol consumption in adult male and female C57BL/6J mice administered saline or psilocybin intraperitoneally as a single dose of 0.1, 0.5, 1.0 or 2.0 mg/kg and provided 20% ethanol utilizing a two-bottle choice alcohol drinking paradigm. Ethanol was provided continuously for 3 days immediately following the administration of psilocybin, then withheld for 2 days, and then provided continuously for two subsequent additional days. A multilevel model (MLM) for repeated measures was used to compare ethanol consumption and preference in psilocybin-treated groups versus controls. Ethanol consumption and preference were reduced in male mice during the 3-day interval that immediately followed psilocybin administration. The effect of psilocybin on ethanol consumption was dose-related and was consistent across the 3-day interval at dosages of 0.5 mg/kg or greater. Psilocybin had no effect on consumption or preference when ethanol was subsequently reintroduced after 2 days of withdrawal. In contrast to males, psilocybin had no significant effect on ethanol consumption or preference in female mice at any dosage or time point. The lack of an effect of psilocybin on quinine preference, and its limited interaction with locomotor activity indicated that the observed reduction in voluntary ethanol consumption was not attributable to altered taste perception or motor effects. Total fluid consumption was increased in males at some time points and psilocybin dosages and unchanged in females, and the absence of any decrease in either group at any time point indicated that the observed reduction in ethanol consumption was not mediated by nonspecific effects on consummatory behavior. The finding of a sex-dependent effect of psilocybin on ethanol consumption suggests that the C57BL/6J mouse may provide a useful experimental approach to modeling sex differences in vulnerability to AUD in addition to investigation of the neurobiological basis of the effect of classical psychedelics on alcohol drinking behavior.
引用
收藏
页数:13
相关论文
共 43 条
  • [1] LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice
    Alper, Kenneth
    Dong, Bin
    Shah, Relish
    Sershen, Henry
    Vinod, K. Yaragudri
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [2] Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice
    Becker, HC
    Lopez, MF
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (12) : 1829 - 1838
  • [3] Sex Differences in Animal Models: Focus on Addiction
    Becker, Jill B.
    Koob, George F.
    [J]. PHARMACOLOGICAL REVIEWS, 2016, 68 (02) : 242 - 263
  • [4] DIAGNOSTICS FOR MIXED-MODEL ANALYSIS OF VARIANCE
    BECKMAN, RJ
    NACHTSHEIM, CJ
    COOK, RD
    [J]. TECHNOMETRICS, 1987, 29 (04) : 413 - 426
  • [5] Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats
    Berquist, Michael D.
    Fantegrossi, William E.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2021, 32 (05): : 382 - 391
  • [6] Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial
    Bogenschutz, Michael P.
    Ross, Stephen
    Bhatt, Snehal
    Baron, Tara
    Forcehimes, Alyssa A.
    Laska, Eugene
    Mennenga, Sarah E.
    O'Donnell, Kelley
    Owens, Lindsey T.
    Podrebarac, Samantha
    Rotrosen, John
    Tonigan, J. Scott
    Worth, Lindsay
    [J]. JAMA PSYCHIATRY, 2022, 79 (10) : 953 - 962
  • [7] Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
    Bogenschutz, Michael P.
    Forcehimes, Alyssa A.
    Pommy, Jessica A.
    Wilcox, Claire E.
    Barbosa, P. C. R.
    Strassman, Rick J.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (03) : 289 - 299
  • [8] Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
    Brown, Randall T.
    Nicholas, Christopher R.
    Cozzi, Nicholas V.
    Gassman, Michele C.
    Cooper, Karen M.
    Muller, Daniel
    Thomas, Chantelle D.
    Hetzel, Scott J.
    Henriquez, Kelsey M.
    Ribaudo, Alexandra S.
    Hutson, Paul R.
    [J]. CLINICAL PHARMACOKINETICS, 2017, 56 (12) : 1543 - 1554
  • [9] A non-hallucinogenic psychedelic analogue with therapeutic potential
    Cameron, Lindsay P.
    Tombari, Robert J.
    Lu, Ju
    Pell, Alexander J.
    Hurley, Zefan Q.
    Ehinger, Yann
    Vargas, Maxemiliano V.
    McCarroll, Matthew N.
    Taylor, Jack C.
    Myers-Turnbull, Douglas
    Liu, Taohui
    Yaghoobi, Bianca
    Laskowski, Lauren J.
    Anderson, Emilie, I
    Zhang, Guoliang
    Viswanathan, Jayashri
    Brown, Brandon M.
    Tjia, Michelle
    Dunlap, Lee E.
    Rabow, Zachary T.
    Fiehn, Oliver
    Wulff, Heike
    McCorvy, John D.
    Lein, Pamela J.
    Kokel, David
    Ron, Dorit
    Peters, Jamie
    Zuo, Yi
    Olson, David E.
    [J]. NATURE, 2021, 589 (7842) : 474 - +
  • [10] Trial of Psilocybin versus Escitalopram for Depression
    Carhart-Harris, Robin
    Giribaldi, Bruna
    Watts, Rosalind
    Baker-Jones, Michelle
    Murphy-Beiner, Ashleigh
    Murphy, Roberta
    Martell, Jonny
    Blemings, Allan
    Erritzoe, David
    Nutt, David J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) : 1402 - 1411